NCT01854385View on ClinicalTrials.gov

Sumatriptan as Treatment for Post-traumatic Headache

PHASE2CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

June 30, 2013

Primary Completion Date

February 28, 2018

Study Completion Date

February 28, 2018

Conditions
Post-traumatic Headache
Interventions
DRUG

Sumatriptan 100 mg

This is a single-arm, unblinded study of treatment for post-traumatic headache with the open label medication sumatriptan and is being undertaken to test necessary study instruments and procedures, establish feasibility and determine side effects in a population with complicated mild, moderate and severe TBI.

Trial Locations (2)

98104

Harborview Medical Center, Seattle

98195

University of Washington Medical Center, Seattle

All Listed Sponsors
lead

University of Washington

OTHER

NCT01854385 - Sumatriptan as Treatment for Post-traumatic Headache | Biotech Hunter | Biotech Hunter